BAXTER INTERNATIONAL INC
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
BAX$26.41+2.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (unaudited)
(in millions, except share information)
| March 31,2025 | December 31,2024 | |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $2,294 | 1,764 |
| Accounts receivable, net of allowances of $66 in 2025 and $71 in 2024 | 1,646 | 1,679 |
| Inventories | 2,170 | 2,046 |
| Prepaid expenses and other current assets | 925 | 753 |
| Current assets of discontinued operations | — | 2,611 |
| Total current assets | 7,035 | 8,853 |
| Property, plant and equipment, net | 2,717 | 2,870 |
| Goodwill | 5,338 | 5,275 |
| Other intangible assets, net | 5,081 | 5,223 |
| Operating lease right-of-use assets | 301 | 306 |
| Other non-current assets | 832 | 755 |
| Non-current assets of discontinued operations | — | 2,500 |
| Total assets | $21,304 | $25,782 |
| Current liabilities: | ||
| Short-term debt | $11 | $2,126 |
| Current maturities of long-term debt and finance lease obligations | 651 | 626 |
| Accounts payable | 963 | 968 |
| Accrued expenses and other current liabilities | 1,856 | 1,861 |
| Current liabilities of discontinued operations | — | 930 |
| Total current liabilities | 3,481 | 6,511 |
| Long-term debt and finance lease obligations, less current portion | 9,412 | 10,374 |
| Operating lease liabilities | 235 | 243 |
| Other non-current liabilities | 1,122 | 1,076 |
| Non-current liabilities of discontinued operations | — | 554 |
| Total liabilities | 14,250 | 18,758 |
| Commitments and contingencies | ||
| Equity: | ||
| Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2025 and 2024 | 683 | 683 |
| Common stock in treasury, at cost, 170,414,885 shares in 2025 and 172,567,636 shares in 2024 | (10,937) | (11,059) |
| Additional contributed capital | 6,309 | 6,421 |
| Retained earnings | 14,968 | 14,929 |
| Accumulated other comprehensive loss | (3,942) | (4,010) |
| Total Baxter stockholders’ equity | 7,081 | 6,964 |
| Noncontrolling interests | (27) | 60 |
| Total equity | 7,054 | 7,024 |
| Total liabilities and equity | $21,304 | $25,782 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.